ES2194012T3 - Epitopo p1a1 y p1a2 de la gpiii a de plaquetas, su preparacion y uso. - Google Patents

Epitopo p1a1 y p1a2 de la gpiii a de plaquetas, su preparacion y uso.

Info

Publication number
ES2194012T3
ES2194012T3 ES93900656T ES93900656T ES2194012T3 ES 2194012 T3 ES2194012 T3 ES 2194012T3 ES 93900656 T ES93900656 T ES 93900656T ES 93900656 T ES93900656 T ES 93900656T ES 2194012 T3 ES2194012 T3 ES 2194012T3
Authority
ES
Spain
Prior art keywords
disclosed
polypeptides
those
epitopo
gpiii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93900656T
Other languages
English (en)
Inventor
Ronald D Bowditch
Robert Mcmillan
Mark H Ginsberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Application granted granted Critical
Publication of ES2194012T3 publication Critical patent/ES2194012T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70557—Integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2848—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/24—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a MBP (maltose binding protein)-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)

Abstract

SE DESCRIBEN POLIPEPTIDOS Y POLIPEPTIDOS DE FUSION QUE IMITAN INMUNOLOGICAMENTE LOS DETERMINANTES NATIVOS P1A1 Y P1A2 DE PROTEINA DE PLAQUETA GPIIIA. TAMBIEN SE DESCRIBEN SEGMENTOS DE ADN Y MOLECULAS DE ADN RECOMBINADAS QUE CODIFICAN ESTOS POLIPEPTIDOS Y POLIPEPTIDOS DE FUSION Y LOS METODOS PARA EXPRESAR Y USAR ESTOS DETERMINANTES. TAMBIEN SE DESCRIBEN ANTICUERPOS QUE INMUNOREACCIONAN CON UN DETERMINANTE U OTRO, PERO NO CON AMBOS, Y LOS METODOS PARA PREPARAR Y USAR ESTOS ANTICUERPOS.
ES93900656T 1991-12-09 1992-11-24 Epitopo p1a1 y p1a2 de la gpiii a de plaquetas, su preparacion y uso. Expired - Lifetime ES2194012T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/808,457 US5939524A (en) 1991-12-09 1991-12-09 Platelet GPIII P1A1 and P1A2 epitopes, their preparation and use

Publications (1)

Publication Number Publication Date
ES2194012T3 true ES2194012T3 (es) 2003-11-16

Family

ID=25198810

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93900656T Expired - Lifetime ES2194012T3 (es) 1991-12-09 1992-11-24 Epitopo p1a1 y p1a2 de la gpiii a de plaquetas, su preparacion y uso.

Country Status (11)

Country Link
US (1) US5939524A (es)
EP (1) EP0625157B1 (es)
JP (1) JP4053084B2 (es)
AT (1) ATE233811T1 (es)
AU (1) AU680190B2 (es)
CA (1) CA2125486C (es)
DE (1) DE69232945T2 (es)
DK (1) DK0625157T3 (es)
ES (1) ES2194012T3 (es)
PT (1) PT625157E (es)
WO (1) WO1993012127A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7442370B2 (en) * 2001-02-01 2008-10-28 Biogen Idec Ma Inc. Polymer conjugates of mutated neublastin
US7276580B2 (en) * 2001-03-12 2007-10-02 Biogen Idec Ma Inc. Neurotrophic factors
JP4571776B2 (ja) * 2002-11-05 2010-10-27 Ｊｘ日鉱日石エネルギー株式会社 潤滑油組成物
EP2322205A1 (en) 2003-04-18 2011-05-18 Biogen Idec MA Inc. Polymer-conjugated glycosylated neublastin
GB0315754D0 (en) * 2003-07-04 2003-08-13 Univ Aberdeen Pharmaceutical compositions
CA2577755C (en) * 2004-08-19 2014-05-13 Biogen Idec Ma Inc. Neublastin variants
DE602005022082D1 (de) 2004-08-19 2010-08-12 Biogen Idec Inc Rückfaltung von proteinen der transforming-growth-factor-beta-familie
TWI501774B (zh) 2006-02-27 2015-10-01 Biogen Idec Inc 神經性病症之治療
ES2450065T3 (es) * 2006-03-01 2014-03-21 Biogen Idec Ma Inc. Composiciones y métodos para la administración de proteínas de la familia de ligandos del GDNF
GB0701048D0 (en) * 2007-01-18 2007-02-28 Univ Aberdeen A composition
TWI445544B (zh) 2007-05-01 2014-07-21 Biogen Idec Inc 增進血管形成之組合物及方法
WO2009020964A2 (en) * 2007-08-08 2009-02-12 Biogen Idec Ma Inc. Anti-neublastin antibodies and uses thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3654090A (en) * 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies
NL154598B (nl) * 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US4016043A (en) * 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4356270A (en) * 1977-11-08 1982-10-26 Genentech, Inc. Recombinant DNA cloning vehicle
SE428332B (sv) * 1979-03-08 1983-06-20 Wallac Oy Forfarande for fluorescensspektroskopisk bestemning av biologiskt aktivt emne, sasom hapten, antikropp eller antigen
US4403036A (en) * 1980-12-02 1983-09-06 University Of Iowa Research Foundation Genetic reagents for generating plasmids containing multiple copies of DNA segments
US4416988A (en) * 1980-12-23 1983-11-22 Harvey Rubin Detection and isolation of enkephalin mRNA using a synthetic oligodeoxynucleotide
US4714681A (en) * 1981-07-01 1987-12-22 The Board Of Reagents, The University Of Texas System Cancer Center Quadroma cells and trioma cells and methods for the production of same
US4493795A (en) * 1983-10-17 1985-01-15 Syntex (U.S.A.) Inc. Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
US4599231A (en) * 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4599230A (en) * 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4707404A (en) * 1984-04-03 1987-11-17 Mitsubishi Paper Mills, Ltd. Thermal transfer recording material
US4818678A (en) * 1984-05-04 1989-04-04 Scripps Clinic And Research Foundation Diagnostic system for the detection of cytomegalovirus
US4683136A (en) * 1985-03-06 1987-07-28 Scripps Clinic And Research Foundation Proteinaceous antigens with conformation-independent and conformation-dependent determinants
US4631211A (en) * 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4882145A (en) * 1986-12-09 1989-11-21 Scripps Clinic And Research Foundation T cell epitopes of the hepatitis B virus nucleocapsid protein
US4828527A (en) * 1987-12-04 1989-05-09 Donald Spector Play character
EP0452364B1 (en) * 1988-12-22 2002-05-22 Genentech, Inc. Method for preparing water soluble polypeptides
US5091302A (en) * 1989-04-27 1992-02-25 The Blood Center Of Southeastern Wisconsin, Inc. Polymorphism of human platelet membrane glycoprotein iiia and diagnostic and therapeutic applications thereof
US5177188A (en) * 1990-12-03 1993-01-05 The Scripps Research Institute Methods and compositions for diagnosing chronic immune thrombocytopenic purpura

Also Published As

Publication number Publication date
AU3224993A (en) 1993-07-19
PT625157E (pt) 2003-07-31
JP4053084B2 (ja) 2008-02-27
ATE233811T1 (de) 2003-03-15
AU680190B2 (en) 1997-07-24
DE69232945T2 (de) 2003-12-04
EP0625157B1 (en) 2003-03-05
DE69232945D1 (de) 2003-04-10
JPH07502121A (ja) 1995-03-02
EP0625157A1 (en) 1994-11-23
CA2125486C (en) 1999-09-07
DK0625157T3 (da) 2003-06-16
US5939524A (en) 1999-08-17
EP0625157A4 (en) 1995-06-28
WO1993012127A1 (en) 1993-06-24
CA2125486A1 (en) 1993-06-24

Similar Documents

Publication Publication Date Title
DK37591A (da) Fusionsprotein fra paramyxovirus, fremgangsmaade til fremstilling deraf under anvendelse af rekombinant baculovirus-ekspressionsvektor, vaccine indeholdende proteinet samt dets anvendelse
DK0757717T3 (da) Papillomavirusvacciner
ATE325882T1 (de) Polypeptide, die mit alfalfamosaikviralen oder ilarviralen kapsiden fusioniert sind
ATE335078T1 (de) Überexpression von säugetier- und virusproteinen
HUP9902438A2 (hu) Parapoxvírus vektorok
DE59708952D1 (de) Fusionspolypeptid zur beeinflussung von wechselwirkungen zwischen proteinen
DE69738586D1 (de) Hohe expressionsrate von proteinen
ATE198491T1 (de) System zur expression von heterologen antigenen als fusionsproteine
ES2128362T3 (es) Fragmentos de proteinas de prion.
PT90574A (pt) Processo de preparacao de polipeptidos e de determinacao da presenca de anticorpos de proteina latente anti-virus do papiloma
DK82784D0 (da) Fremgangsmade til fremstilling af lyofiliserede, adsorberede polyvalente vacciner
ES2194012T3 (es) Epitopo p1a1 y p1a2 de la gpiii a de plaquetas, su preparacion y uso.
FI960888A0 (fi) Protokadheriiniproteiineja ja niiden käyttö
DK219087A (da) Vektorsystem til brug ved transformation af trichoderma, transformerede trichodermastammer og fremgangsmaade til fremstilling af proteiner heri
DE69841015D1 (de) Intrazelluläre herstellung von verkürztem hepatitis c-polypeptid e2
AU7423391A (en) Dna constructs for the expression of proteins in the mammary gland of transgenetic mammals
NO922421D0 (no) Collagenbindende protein, samt fremstilling derav
IT8021411A0 (it) Polipeptide sintetico attivo come antigene, e procedimento per la sua preparazione.
FI870501A (fi) Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut
DE69111429D1 (de) Monoklonale antikörper, die einen unterschied zwischen nativproteinen und proteinen mit einer modifizierten sequenz machen.
MX9701904A (es) Proteinas de enlace de pka novedosas y usos de las mismas.
ATE128717T1 (de) Schizosaccharomyces-spezifische polypeptide.